Recommendations for respiratory syncytial virus surveillance at the national level
Open Access
- 22 April 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (3) , 2003766
Abstract
Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infections and hospitalisations among young children and is globally responsible for many deaths in young children, especially in infants aged <6 months. Furthermore, RSV is a common cause of severe respiratory disease and hospitalisation among older adults. The development of new candidate vaccines and monoclonal antibodies highlights the need for reliable surveillance of RSV. In the European Union (EU), no up-to-date general recommendations on RSV surveillance are currently available. Based on outcomes of a workshop with 29 European experts in the field of RSV virology, epidemiology and public health, we provide recommendations for developing a feasible and sustainable national surveillance strategy for RSV that will enable harmonisation and data comparison at the European level. We discuss three surveillance components: active sentinel community surveillance, active sentinel hospital surveillance and passive laboratory surveillance, using the EU acute respiratory infection and World Health Organization (WHO) extended severe acute respiratory infection case definitions. Furthermore, we recommend the use of quantitative reverse transcriptase PCR-based assays as the standard detection method for RSV and virus genetic characterisation, if possible, to monitor genetic evolution. These guidelines provide a basis for good quality, feasible and affordable surveillance of RSV. Harmonisation of surveillance standards at the European and global level will contribute to the wider availability of national level RSV surveillance data for regional and global analysis, and for estimation of RSV burden and the impact of future immunisation programmes.Keywords
Funding Information
- Innovative Medicines Initiative (grant agreement 116019)
This publication has 78 references indexed in Scilit:
- Estimates of Excess Medically Attended Acute Respiratory Infections in Periods of Seasonal and Pandemic Influenza in Germany from 2001/02 to 2010/11PLOS ONE, 2013
- Latitudinal Variations in Seasonal Activity of Influenza and Respiratory Syncytial Virus (RSV): A Global Comparative ReviewPLOS ONE, 2013
- Viral Shedding and Immune Responses to Respiratory Syncytial Virus Infection in Older AdultsThe Journal of Infectious Diseases, 2013
- Risk Factors for Severe Respiratory Syncytial Virus Lower Respiratory Tract InfectionThe Open Microbiology Journal, 2011
- Diagnosis of Respiratory Syncytial Virus InfectionThe Open Microbiology Journal, 2011
- Comparison of Direct Fluorescence Assay and Real-Time RT-PCR as Diagnostics for Respiratory Syncytial Virus in Young ChildrenJournal of Tropical Medicine, 2011
- Swabbing for respiratory viral infections in older patients: a comparison of rayon and nylon flocked swabsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periodsEpidemiology and Infection, 2007
- Toward a National Framework for the Secondary Use of Health Data: An American Medical Informatics Association White PaperJournal of the American Medical Informatics Association, 2007
- Comparison of Flocked and Rayon Swabs for Collection of Respiratory Epithelial Cells from Uninfected Volunteers and Symptomatic PatientsJournal of Clinical Microbiology, 2006